All nigella sativa studies

c19early.org COVID-19 treatment researchNigella SativaNigella Sativa (more..)

Acetaminophen	Meta
Aspirin	Meta
Ibuprofen	Meta
Indomethacin	Meta
Close

Diet	Meta
Exercise	Meta
Sleep	Meta
Sun	Meta
Close

Antiandrogens⏵

All	Meta
Proxalutamide	Meta
Spironolactone	Meta
Close

Selenium	Meta
Zinc	Meta
Close

Adintrevimab	Meta
Bamlaniv../e..	Meta
Bebtelovimab	Meta
Casirivimab/i..	Meta
Sotrovimab	Meta
Tixagev../c..	Meta
Close

Naso/orophar..⏵

Alkalinization	Meta
Cetylpyridin..	Meta
Chlorhexidine	Meta
Hydrogen Per..	Meta
Iota-carragee..	Meta
Nitric Oxide	Meta
Povidone-Iod..	Meta
Close

Vitamin A	Meta
Vitamin B9	Meta
Vitamin C	Meta
Vitamin D	Meta
Close

Home Adoption Other Treatments

All Studies Meta Analysis Recent:

Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription

Banerjee et al., Natural Product Research, doi:10.1080/14786419.2021.2018430

Dec 2021

Twitter
Facebook

Share

Source PDF All Studies Meta AnalysisMeta

In Silico study showing nigella sativa docking to SARS CoV-2 Nsp3 and host inflammatory proteins, which may inhibit viral replication.

15 preclinical studies support the efficacy of nigella sativa for COVID-19:

12 In Silico studies Ali, Banerjee, Bouchentouf, Duru, Esharkawy, Hardianto, Khan, Maiti, Mir, Miraz, Rizvi, Sherwani

2 In Vitro studies Esharkawy, Sherwani

1 In Vivo animal study Maiti

Important missing comments or errors? Let us know.

1. Ali et al., Computational Prediction of Nigella sativa Compounds as Potential Drug Agents for Targeting Spike Protein of SARS-CoV-2, Pakistan BioMedical Journal, doi:10.54393/pbmj.v6i3.853.pakistanbmj.com, doi.org.

2. Banerjee et al., Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription, Natural Product Research, doi:10.1080/14786419.2021.2018430.tandfonline.com, doi.org.

3. Bouchentouf et al., Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study, ChemRxiv, doi:10.26434/chemrxiv.12055716.v1.chemrxiv.org, doi.org.

4. Duru et al., In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets, Bulletin of the National Research Centre, doi:10.1186/s42269-021-00517-x.springer.com, doi.org.

5. Esharkawy et al., In vitro Potential Antiviral SARS-CoV-19- Activity of Natural Product Thymohydroquinone and Dithymoquinone from Nigela sativia, Bioorganic Chemistry, doi:10.1016/j.bioorg.2021.105587.sciencedirect.com, doi.org.

6. Hardianto et al., Exploring the Potency of Nigella sativa Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations, Indonesian Journal of Chemistry, doi:10.22146/ijc.65951.ac.id, doi.org.

7. Khan et al., Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study, Brazilian Journal of Biology, doi:10.1590/1519-6984.25066.scielo.br, doi.org.

8. Maiti et al., Active-site Molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source Nigella sativa (black cumin) seeds show potent antioxidant role in experimental rats, Research Square, doi:10.21203/rs.3.rs-26464/v1.researchsquare.com, doi.org.

9. Mir et al., Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach, Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2021.09.002.sciencedirect.com, doi.org.

10. Miraz et al., Nigelladine A among Selected Compounds from Nigella sativa Exhibits Propitious Interaction with Omicron Variant of SARS-CoV-2: An In Silico Study, International Journal of Clinical Practice, doi:10.1155/2023/9917306.hindawi.com, doi.org.

11. Rizvi et al., Identifying the Most Potent Dual-Targeting Compound(s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from Nigella sativa: Virtual Screening via Physicochemical Properties, Docking and Dynamic Simulation Analysis, Processes, doi:10.3390/pr9101814.mdpi.com, doi.org.

12. Sherwani et al., Pharmacological Profile of Nigella sativa Seeds in Combating COVID-19 through In-Vitro and Molecular Docking Studies, Processes, doi:10.3390/pr10071346.mdpi.com, doi.org.

Banerjee et al., 22 Dec 2021, peer-reviewed, 6 authors.

In Silico studies are an important part of preclinical research, however results may be very different in vivo.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Nigella Sativa All

Loading..

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Public domain CC0 1.0